← Back to Search

Polyphenol

Resveratrol for Chronic Kidney Disease

N/A

Waitlist Available

Research Sponsored by Diana Jalal

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks

Awards & highlights

Study Summary

This trial will test whether resveratrol can help improve vascular function in patients with CKD by reducing oxidative stress and inflammation.

Who is the study for?

This trial is for individuals with Type II diabetes and moderate chronic kidney disease (CKD stage III). They must be taking certain blood pressure medications for over 3 months. People can't join if they have severe heart failure, recent hospitalization, are on immunosuppressants or anticoagulants, pregnant or not using birth control, consume lots of red wine or resveratrol supplements.Check my eligibility

What is being tested?

The study tests whether resveratrol improves blood vessel function in CKD patients by reducing stress and inflammation markers. Participants will either receive resveratrol or a placebo to compare effects.See study design

What are the potential side effects?

While the side effects aren't detailed here, common ones associated with resveratrol may include digestive issues like nausea and diarrhea, as well as headaches and dizziness.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Vascular endothelial function

Secondary outcome measures

Oxidative stress

Side effects data

From 2013 Phase 2 trial • 24 Patients • NCT02114892

25%

Headache

Abdominal pain

Sickness

100%

80%

60%

40%

20%

Study treatment Arm

Resveratrol

Placebo

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: ResveratrolExperimental Treatment1 Intervention

Patients will receive resveratrol 400 mg PO per day in divided doses of 200 mg in the morning and 200 mg in the evening

Group II: PlaceboPlacebo Group1 Intervention

Patients will receive placebo pill identical in appearance and taste to the supplement

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Resveratrol

2014

Completed Phase 3

~730

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Diana JalalLead Sponsor

1 Previous Clinical Trials

88 Total Patients Enrolled

Media Library

Chronic Kidney Disease Research Study Groups: Resveratrol, Placebo

Chronic Kidney Disease Clinical Trial 2023: Resveratrol Highlights & Side Effects. Trial Name: NCT03597568 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots for participants to join this clinical trial?

"The clinical trial is still accepting patient participants, as indicated by the most recent edit on clinicaltrials.gov which was made in late June 2022. The study's first posting occurred nearly 3 years ago on January 1st 2019."

Answered by AI

Is this clinical experiment open to the geriatric population?

"As per the study's guidelines, applicants must be aged 45 or above and 80 or below to qualify."

Answered by AI

Is there an opportunity for me to participate in this trial?

"To be a viable participant in this clinical trial, candidates must present with endothelial dysregulation and between the ages of 45 to 80. The total number of individuals needed for recruitment is 25."

Answered by AI

What is the current patient enrollment for this investigation?

"Affirmative. The information on clinicaltrials.gov reveals that this investigation is currently open for enrollment, with the initial listing dated January 1st of 2019 and a recent amendment made on June 28th 2022. 25 volunteers are sought from one medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Resveratrol and Vascular Function in CKD

Diana Jalal 2019. "Resveratrol and Vascular Function in CKD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03597568.